Current diabetes mellitus for patients with type 2 diabetes in Germany;Aktuelles diabetes-management für patienten mit typ-2-diabetes in Deutschlan - Ergebnisse der CODE-2® -Studie

Diabetes und Stoffwechsel

Volumn 11, Issue 2, 2002, Pages 55-61

  Liebl, Andreas ^a   Spannheimer, A ^a   Reitberger, U ^a   Wagenpfeil, S ^a   Gortz A ^a  

^a Fachklinik Bad Heilbrunn   (Germany)

Author keywords

Blood lipids; Blood pressure; HbA1c; Medication; Treatment of Type 2 Diabetes

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GERMANY; HEALTH CARE COST; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; QUALITY OF LIFE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

EID: 0036228278     PISSN: 09420037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
2. Guidelines for diabetes care. A desktop guide to type 2 diabetes mellitus. 1998-1999
3. Diabetes and hypertension: An era of clarity or confusion?
4. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: Ecohomic analysis alongside randomised controlled trial (UKPDS 41)
5. Hypertension in diabetes: A good opportunity to practise evidence-based medicine? A commentary on the UKPDS
6. Prävalenz des diabetes mellitus und der folgekrankheiten
7. Quality of diabetes care in a general practice network
8. Drug use and costs of medication in patients with diabetes in Germany
9. Kosten des typ-2-diabetes in Deutschland. Ergebnisse der CODE-2® studie
10. The Scandinavian Simvastatin Survival Study (4S) Group: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease
11. Rapider anstieg der zahl niereninsuffizienter typ-II-diabetiker
12. Health care expenditures for people with diabetes mellitus
13. The economic costs of NIDDM
14. Dealing with co-morbidity and rare complications in a diabetes type 2 cost of illness study
15. Mangelnder erfolg bei der reduktion von amputationen bei diabetikern in Deutschland
16. Association of glycaemia with cardiovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
17. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
18. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
19. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40